Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Global Registry of Patients with Paroxysmal Nocturnal Hemoglobinuria.

Robert Brodsky, Hubert Schrezenmeier, MD, Petra Muus, MD, PhD, Monica Bessler, MD, PhD, Jeffrey Szer, MBBS, FRACP, Bruno Rotoli, MD, Jaroslaw P. Maciejewski, MD, PhD, Gerard Socie, MD, PhD, A. Urbano-Ispizua, MD, Wendell F. Rosse, MD, Yuzuru Kanakura, MD, PhD, Anders Karnell, Camille Bedrosian, MD, Peter Hillmen, MB, ChB, PhD

Blood (2009) 114 (22): 3007.

https://doi.org/10.1182/blood.V114.22.3007.3007

Published: 2009

Journal Articles

Successful Pregnancy Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Long-Term Eculizumab Treatment

Richard Kelly, MD, Louise Arnold, BSc, MA, Stephen J. Richards, PhD, Anita Hill, MD, Charlotte Bomken, MD, John Hanley, MD, Andrew Loughney, MD, PhD, Gus Khursigara, PhD, Russell P. Rother, PhD, Elizabeth Chalmers, MD, Edward Fitzsimons, MD, Ryotaro Nakamura, MD, Anna Gaya, MD, Bruno Rotoli, MD, Antonio M. Risitano, MD, PhD, Joerg Schubert, MD, Peter Hillmen, MB, PhD

Blood (2008) 112 (11): 4576.

https://doi.org/10.1182/blood.V112.11.4576.4576

Published: 2008

Journal Articles

Subcutaneous Alemtuzumab Is Safe and Effective for Treatment of Global or Single-Lineage Immune-Mediated Marrow Failure: A Pilot Study.

Antonio M. Risitano, MD, PhD, Carmine Selleri, MD, Bianca Serio, MD, Ludovica Marando, Andrea Camera, MD, Lucio Catalano, MD, Giulia Scalia, PhD, Luigi Del Vecchio, MD, Bruno Rotoli, MD

Blood (2007) 110 (11): 1692.

https://doi.org/10.1182/blood.V110.11.1692.1692

Published: 2007

Journal Articles

GATA1 Is Over-Expressed in Essential Thrombocytemia

Ciro R. Rinaldi, MD, Donglan Li, MD, Rosanna Ciancia, MD, Marco Picardi, MD, Paola Rinaldi, Vincenzo Martinelli, MD, Giuseppina Nucifora, PhD, Fabrizio Pane, MD, Bruno Rotoli, MD

Blood (2007) 110 (11): 1534.

https://doi.org/10.1182/blood.V110.11.1534.1534

Published: 2007

Journal Articles

Liposomal Cytarabine (Depocyte®) for the Treatment of Meningeal or CNS Disease in Acute Leukemias (AL) and Non-Hodgkin Lymphomas (NHL): A Single Centre Experience.

Andrea Camera, MD, Giuseppe Cerciello, MD, Fabiana Perna, MD, Ciro R. Rinaldi, MD, Elefanti Michele, Silvia Ferrari, Bruno Rotoli, MD

Blood (2006) 108 (11): 4540.

https://doi.org/10.1182/blood.V108.11.4540.4540

Published: 2006

Journal Articles

Subcutaneous Alemtuzumab as Treatment Option for Patients with Severe Aplastic Anemia or Lineage-Restricted Aplasia.

Antonio M. Risitano, MD, PhD, Carmine Selleri, MD, Andrea Camera, MD, Giovanni Gallotta, MD, Fabiana Perna, MD, Giampaolo Copeta, MD, Bruno Rotoli, MD

Blood (2006) 108 (11): 3754.

https://doi.org/10.1182/blood.V108.11.3754.3754

Published: 2006

Journal Articles

Safety and Efficacy of the Terminal Complement Inhibitor Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Interim Shepherd Phase III Clinical Study.

Neal S. Young, MD, Elisabetta Antonioli, MD, Bruno Rotoli, MD, Hubert Schrezenmeier, MD, Jörg Schubert, MD, Alvaro Urbano-Ispizua, MD, Luke Coyle, MD, Carlos de Castro, MD, Chieh-Lin Fu, MD, Jaroslaw P. Maciejewski, MD, PhD, Christopher F. Mojcik, MD, PhD, Russell P. Rother, PhD, Peter Hillmen, MB PhD

Blood (2006) 108 (11): 971.

https://doi.org/10.1182/blood.V108.11.971.971

Published: 2006

Journal Articles

Blockade of Intravascular Hemolysis in PNH with the Terminal Complement Inhibitor Eculizumab Unmasks Low-Level Hemolysis Potentially Occurring through C3 Opsonization.

Anita Hill, MD, Russell P. Rother, PhD, Antonio M. Risitano, PhD, Duncan S. Cole, PhD, Matthew J. Cullen, MSc, Stephen J. Richards, PhD, Carmine Selleri, MD, Patrizia Ricci, BSc, Bruno Rotoli, MD, Lucio Luzzatto, PhD, Peter Hillmen, PhD

Blood (2006) 108 (11): 972.

https://doi.org/10.1182/blood.V108.11.972.972

Published: 2006

Journal Articles

Chromosome Abnormalities in Multiple Myeloma Patients: Impact on Prognosis and Survival.

Lulgia Luciano, MD, Rosamaria De Luca, PhD, Anna Guerriero, PhD, Lucio Catalano, MD, Ferdinando Frigeri, MD, Fara Petruzziello, MD, Fabrizio Pane, MD, Bruno Rotoli, MD

Blood (2006) 108 (11): 5054.

https://doi.org/10.1182/blood.V108.11.5054.5054

Published: 2006

Journal Articles

Imatinib Mesylate Therapy in Late Ph+ Chronic Myeloid Leukemia Patients in Stable Complete Cytogenetic Response after Interferon-Alpha Results in a Very High Complete Molecular Response Rate.

Giuliana Alimena, MD, Massimo Breccia, MD, Luigia Luciano, MD, Fabrizio Quarantelli, PhD, Daniela Diverio, PhD, Barbara Izzo, MD, Biagio De Angelis, Marco Mancini, MD, Roberto Latagliata, MD, Ida Carmosino, MD, Mauro Nanni, PhD, Bruno Rotoli, MD, Franco Mandelli, MD, Fabrizio Pane, MD

Blood (2006) 108 (11): 2158.

https://doi.org/10.1182/blood.V108.11.2158.2158

Published: 2006

Journal Articles

Platelet-Derived Growth Factor Receptor Beta (PDGFRb) Expression in Langerhans Cell Histiocytosis (LCH).

Giovannella Palmieri, MD, Liliana Montella, MD, Viviana Strazzullo, MD, Dolores De Vizio, MD, Lucio Catalano, MD, Bruno Rotoli, MD, Luigi Insabato, MD

Blood (2004) 104 (11): 3809.

https://doi.org/10.1182/blood.V104.11.3809.3809

Published: 2004

NARROW

A Global Registry of Patients with Paroxysmal Nocturnal Hemoglobinuria.

Successful Pregnancy Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Long-Term Eculizumab Treatment

Subcutaneous Alemtuzumab Is Safe and Effective for Treatment of Global or Single-Lineage Immune-Mediated Marrow Failure: A Pilot Study.

GATA1 Is Over-Expressed in Essential Thrombocytemia

Liposomal Cytarabine (Depocyte®) for the Treatment of Meningeal or CNS Disease in Acute Leukemias (AL) and Non-Hodgkin Lymphomas (NHL): A Single Centre Experience.

Subcutaneous Alemtuzumab as Treatment Option for Patients with Severe Aplastic Anemia or Lineage-Restricted Aplasia.

Safety and Efficacy of the Terminal Complement Inhibitor Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Interim Shepherd Phase III Clinical Study.

Blockade of Intravascular Hemolysis in PNH with the Terminal Complement Inhibitor Eculizumab Unmasks Low-Level Hemolysis Potentially Occurring through C3 Opsonization.

Chromosome Abnormalities in Multiple Myeloma Patients: Impact on Prognosis and Survival.

Imatinib Mesylate Therapy in Late Ph+ Chronic Myeloid Leukemia Patients in Stable Complete Cytogenetic Response after Interferon-Alpha Results in a Very High Complete Molecular Response Rate.

Platelet-Derived Growth Factor Receptor Beta (PDGFRb) Expression in Langerhans Cell Histiocytosis (LCH).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only